Diverse phenotypes and transfusion requirements due to interaction of β-thalassemias with triplicated α-globin genes
- 29 August 2015
- journal article
- Published by Springer Science and Business Media LLC in Annals of Hematology
- Vol. 94 (12), 1953-1958
- https://doi.org/10.1007/s00277-015-2479-8
Abstract
Co-inheritance of triplicated α-genes can alter the clinical and hematological phenotypes of β-thalassemias. We evaluated the phenotypic diversity and transfusion requirements in β-thalassemia heterozygotes, homozygotes, and normal individuals with associated α-gene triplication. Clinical and hematological evaluation was done and the β-thalassemia mutations characterized by a covalent reverse dot blot hybridization/amplification refractory mutation system. Alpha-globin gene triplication was assessed by multiplex PCR. During the last 2.5 years, 181 β-thalassemia patients and β-thalassemia carriers with an unusual clinical presentation were referred to us for screening for the presence of associated α-globin gene triplication. Twenty-nine of them had associated α-gene triplication (3 β-thalassemia homozygotes or compound heterozygotes and 26 β-thalassemia heterozygotes). One β-thalassemia compound heterozygote [IVS 1–5 (G → C) + CD 41/42 (−CTTT)] was anemic at birth and required blood transfusions unusually early by 6 weeks of age. The second patient (4.5 years) was also clinically severe and became transfusion dependent in spite of having one mild β-thalassemia mutation [Capsite +1 (A → C)]. The third case (3.5 years) who was homozygous for a mild β-gene mutation [−88 (C → T)] with α gene triplication was untransfused. The 26 β-thalassemia heterozygotes with associated triplicated α-genes presented variably, with a β-thalassemia intermedia-like presentation. While screening the family members of all these cases, we found another 10 β-thalassemia heterozygotes and 9 normal individuals with α-globin gene triplication; however, all of them were asymptomatic. Beta-thalassemia carriers, homozygotes, and compound heterozygotes with an unusual presentation should be screened for the possible presence of associated α-globin gene triplication which could influence the clinical and hematological presentation.Keywords
This publication has 15 references indexed in Scilit:
- Non-transfusion-dependent thalassemiasHaematologica, 2013
- -Thalassemia Intermedia: A Clinical PerspectiveCold Spring Harbor Perspectives in Medicine, 2012
- How I treat thalassemiaBlood, 2011
- Pathophysiology and therapy for haemoglobinopathies; Part II: thalassaemiasExpert Reviews in Molecular Medicine, 2006
- A rapid and reliable 7-deletion multiplex polymerase chain reaction assay for α-thalassemiaBlood, 2001
- The Thalassaemia SyndromesPublished by Wiley ,2001
- Different hematological phenotypes caused by the interaction of triplicated α-globin genes and heterozygous β-thalassemiaAmerican Journal of Hematology, 1997
- The triplicated α‐globin gene locus in β‐thalassaemia heterozygotes: clinical, haematological, biosynthetic and molecular studiesBritish Journal of Haematology, 1996
- Alpha Globin Gene Triplication in Severe Heterozygous Beta ThalassemiaActa Haematologica, 1985
- Triplicated alpha-globin loci in humans.Proceedings of the National Academy of Sciences of the United States of America, 1980